BioAffinity Technologies Inc [BIAF] fell -85.06% so far this year. What now?

BioAffinity Technologies Inc [NASDAQ: BIAF] closed the trading session at $0.24 on 2025-08-29. The day’s price range saw the stock hit a low of $0.241, while the highest price level was $0.2529.

The stocks have a year to date performance of -85.06 percent and weekly performance of -4.53 percent. The stock has been moved at -51.58 percent over the last six months. The stock has performed -23.63 percent around the most recent 30 days and changed -13.54 percent over the most recent 3-months.

If compared to the average trading volume of 4.55M shares, BIAF reached to a volume of 169932 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about BioAffinity Technologies Inc [BIAF]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BIAF shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BIAF stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

BIAF stock trade performance evaluation

BioAffinity Technologies Inc [BIAF] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -4.53. With this latest performance, BIAF shares dropped by -23.63% in over the last four-week period, additionally sinking by -51.58% over the last 6 months – not to mention a drop of -73.40% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BIAF stock in for the last two-week period is set at 38.89, with the RSI for the last a single of trading hit 0.0202, and the three-weeks RSI is set at 0.0284 for BioAffinity Technologies Inc [BIAF]. The present Moving Average for the last 50 days of trading for this stock 0.2906, while it was recorded at 0.2472 for the last single week of trading, and 0.5581 for the last 200 days.

BioAffinity Technologies Inc [BIAF]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and BioAffinity Technologies Inc [BIAF] shares currently have an operating margin of -131.01% and a Gross Margin at 22.41%. BioAffinity Technologies Inc’s Net Margin is presently recorded at -152.18%.

BioAffinity Technologies Inc (BIAF) Capital Structure & Debt Analysis

BioAffinity Technologies Inc (BIAF) Efficiency & Liquidity Metrics

BioAffinity Technologies Inc (BIAF) Efficiency & Liquidity Metrics

From an operational efficiency perspective, BioAffinity Technologies Inc. (BIAF) effectively leverages its workforce, generating an average of -$205087.72 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.64% and a Quick Ratio of 0.63%, indicating strong ability to cover short-term liabilities.

Earnings per share (EPS) analysis for BioAffinity Technologies Inc [BIAF] stock

With the latest financial reports released by the company, BioAffinity Technologies Inc posted -0.16/share EPS, while the average EPS was predicted by analysts to be reported at -0.15/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.01. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BIAF.

BioAffinity Technologies Inc [BIAF]: Institutional Ownership

There are presently around $1.46%, or 1.80%% of BIAF stock, in the hands of institutional investors. The top three institutional holders of BIAF stocks are: VANGUARD GROUP INC with ownership of 0.17 million shares, which is approximately 1.5101%. GEODE CAPITAL MANAGEMENT, LLC, holding 69600.0 shares of the stock with an approximate value of $$0.15 million in BIAF stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $$60232.0 in BIAF stock with ownership which is approximately 0.2448%.

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.